摘要
目的提高疫苗犹豫认识度,为进一步制定新冠病毒疫苗犹豫应对措施提供依据。方法通过文献检索,对疫苗犹豫现象、新冠病毒疫苗研制和上市现状、新冠病毒疫苗犹豫现状、影响因素和应对措施进行综述。结果各国新冠病毒疫苗研制竞赛如火如荼,国内外均有不同类型疫苗上市使用;各国新冠病毒疫苗犹豫差异较大,与调查时机、国家地域、人群选择等均有关系;新冠病毒疫苗犹豫受疫苗、个人、认知等方面因素影响。结论为减少新冠病毒疫苗犹豫,建议采取的措施有:政府主导,各级有效发挥监管作用;渠道畅通,保证疫苗信息透明准确;专业培训,全面提升疫苗接种信心。
OBJECTIVE To improve the awareness of vaccine hesitancy and provide the basis for taking effective measures for the COVID-19vaccine hesitancy in China.METHODS Through literature search,the phenomena of vaccine hesitancy,the development and marketing status of COVID-19vaccine,the hesitancy status,the influencing factors and countermeasures were reviewed.RESULTS The competition for the development of COVID-19 vaccine in various countries was fierce,and there were different types of vaccines available at home and abroad.The hesitancy of COVID-19vaccine varied greatly among different countries,which was related to the timing of investigation,country and region,and population selection,etc.The hesitation of COVID-19vaccine was affected by factors such as vaccines,personal,and cognition.CONCLUSIONIn order to reduce the hesitation of COVID-19 vaccine,the following measures are recommended,government-led,effective supervision at all levels;smooth channels to ensure the transparency and accuracy of vaccine information;professional training to comprehensively enhance the confidence of vaccination.
作者
刘春梓
庄英杰
于燕波
张昕
LIU Chun-zi;ZHUANG Ying-jie;YU Yan-bo;ZHANG Xin(The fifth medical center of PLA general hospital,Beijing100039,China)
出处
《中华医院感染学杂志》
CAS
CSCD
北大核心
2021年第19期2905-2909,共5页
Chinese Journal of Nosocomiology
基金
中央保健课题基金资助项目(2020YB53)。
关键词
新冠病毒疫苗
疫苗犹豫
现状
应对
COVID-19vaccine
Vaccine hesitancy
Status
Countermeasure
作者简介
刘春梓(1975-),女,硕士,副主任护师,研究方向:传染病与肿瘤护理;通讯作者:张昕,E-mail:zhangxinliu@sina.com。
